References
- 1SolimenaM, FolliF, Denis-DoniniS, ComiGC, PozzaG, De CamilliP, et al. Autoantibodies to glutamic acid decarboxylase in a patient with Stiff-Man Syndrome, epilepsy, and type I diabetes mellitus. N Engl J Med 1990;322(22):1555–1560.2135382
- 2AriñoH, Gresa-ArribasN, BlancoY, Martínez-HernándezE, SabaterL, Petit-PedrolM, et al. Cerebellar ataxia and glutamic acid decarboxylase antibodies: immunologic profile and long-term effect of immunotherapy. JAMA Neurol 2014;71(8):1009–1016. doi: 10.1001/jamaneurol.2014.101124934144
- 3RakocevicG, RajuR, Semino-MoraC, DalakasMC Stiff person syndrome with cerebellar disease and high-titer anti-GAD antibodies. Neurology 2006;67(6):1068–1070. doi: 10.1212/01.wnl.0000237558.83349.d017000981
- 4SchaeferSM, MoellerJJ Anti-GAD antibody syndrome with concomitant cerebellar ataxia, stiff person syndrome, and limbic encephalitis. Neurol Clin Pract 2015;5(6):502–504. doi: 10.1212/CPJ.000000000000014829595815
- 5KonoS, MiyajimaH, SugimotoM, SuzukiY, TakahashiY, HishidaA Stiff-person syndrome associated with cerebellar ataxia and high glutamic acid decarboxylase antibody titer. Intern Med 2001;40(9):968–971.11579968
- 6AliF, RowleyM, JayakrishnanB, TeuberS, GershwinME, MackayIR Stiff-person syndrome (SPS) and anti-GAD-related CNS degenerations: protean additions to the autoimmune central neuropathies. J Autoimmun 2011;37(2):79–87. doi: 10.1016/j.jaut.2011.05.00521680149
- 7SarvaH, DeikA, UllahA, SevertWL, DiseaseP, SinaiM, et al. Clinical spectrum of Stiff Person Syndrome: a review of recent reports. Tremor Other Hyperkinet Mov (N Y) 2016;6:34.